Literature DB >> 32897289

Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy.

Michael G Nanna1,2, Sean T Chen2, Adam J Nelson1, Ann Marie Navar1,2, Eric D Peterson1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32897289      PMCID： PMC7489390          DOI： 10.1001/jamainternmed.2020.2750

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  7 in total

Review 1.  Polypharmacy in Older Heart Failure Patients: a Multidisciplinary Approach.

Authors:  Smrithi Sukumar; Ariela R Orkaby; Janice B Schwartz; Zachary Marcum; James L Januzzi; Muthiah Vaduganathan; Haider J Warraich
Journal:  Curr Heart Fail Rep       Date:  2022-06-20

Review 2.  The need for increased pragmatism in cardiovascular clinical trials.

Authors:  Muhammad Shariq Usman; Harriette G C Van Spall; Stephen J Greene; Ambarish Pandey; Darren K McGuire; Ziad A Ali; Robert J Mentz; Gregg C Fonarow; John A Spertus; Stefan D Anker; Javed Butler; Stefan K James; Muhammad Shahzeb Khan
Journal:  Nat Rev Cardiol       Date:  2022-05-17       Impact factor: 49.421

Review 3.  Inclusion and diversity in clinical trials: Actionable steps to drive lasting change.

Authors:  Michelle D Kelsey; Bray Patrick-Lake; Raolat Abdulai; Uli C Broedl; Adam Brown; Elizabeth Cohn; Lesley H Curtis; Chris Komelasky; Michael Mbagwu; George A Mensah; Robert J Mentz; Amesika Nyaku; Stephanie O Omokaro; Judy Sewards; Kendal Whitlock; Xinzhi Zhang; Gerald S Bloomfield
Journal:  Contemp Clin Trials       Date:  2022-03-29       Impact factor: 2.261

Review 4.  An Update on Medication Use in Older Adults: a Narrative Review.

Authors:  Heather E Barry; Carmel M Hughes
Journal:  Curr Epidemiol Rep       Date:  2021-07-20

5.  Disparities by sex in P2Y12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y12 inhibitor new user retrospective cohort analysis of US Medicare claims data.

Authors:  Ryan P Hickson; Anna M Kucharska-Newton; Jo E Rodgers; Betsy L Sleath; Gang Fang
Journal:  BMJ Open       Date:  2021-12-01       Impact factor: 2.692

6.  Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method.

Authors:  Milly A van der Ploeg; Rosalinde K E Poortvliet; Wilco P Achterberg; Simon P Mooijaart; Jacobijn Gussekloo; Yvonne M Drewes
Journal:  BMC Geriatr       Date:  2022-05-05       Impact factor: 4.070

7.  Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project.

Authors:  Eric A Secemsky; Neel Butala; Aishwarya Raja; Rohan Khera; Yongfei Wang; Jeptha P Curtis; Thomas M Maddox; Salim S Virani; Ehrin J Armstrong; Kendrick A Shunk; Ralph G Brindis; Deepak Bhatt; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2021-08-10       Impact factor: 7.514
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.